中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

2004年拉米夫定临床应用专家共识

拉米夫定临床应用专家组

引用本文:
Citation:

2004年拉米夫定临床应用专家共识

详细信息
  • 中图分类号: R96

  • [1] LiawYF , LeungN , GuanR , etal.Asian-PacificconsensusstatementonthemanagementofchronichepatitisB :anupdate[J].JGastroenterolHepatol, 2003, 18∶239-245.
    [2]姚光弼, 王宝恩, 崔振宇, 等.拉米夫定治疗慢性乙型肝炎三年疗效观察[J], 中华内科杂志, 2003, 42∶383-387.
    [3]拉米夫定临床应用专家指导小组.2000年拉米夫定临床应用指导意见[J].中华肝脏病杂志, 2000, 8∶249-250.
    [4] 拉米夫定临床应用专家指导小组.2003年拉米夫定临床应用专家共识[J].中华传染病杂志, 2003, 21∶301-304.
    [5] TheEASLJury.EASLinternationalconsensusconferenceonhepatitisB[J].JHepatol, 2003, 38∶533-540.
    [6] LokAS , McMahonBJ.ChronichepatitisB[J].Hepatology, 2001, 34∶1225-1241.
    [7] LiLL , ChunTW , YinML , etal.Prophylacticlamivudinepreventshep atitisBreactivationandmortalityinpatientsreceivingimmunosuppressionandchemotherapy[J].Hepatology, 2000, 32 (Pt2) ∶1183.
    [8] LiawYF , SungJJY .ChowWC .etal.EffectsoflamivudineondiseaseprogressionanddevelopmentoflivercancerinadvancedchronichepatitisB :aprospectivedouble-blinedplacebo-controlledclinicaltrial[J].Hepatology, 2003, 38 (Suppl) 1∶262A .
    [9] FontanaRJ.MangementofpatientswithdecompensatedHBVcirrhosis[J].Seminarsinliverdisease.2003, 23∶89-100.
    [10] HomX , LittleNR , GardnerSD , etal.PredictorsofvirologicresponsetoLamivudinetreatmentinchildrenwithchronichepatitisBinfection[J].PediatrInfectDisJ, 2004, 23∶441-445.
    [11] JonasMM , KelleyDA , MizerskiJ , etal.ClinictrialoflamivudineinchildrenwithchronichepatitisB[J].NEngJMed, 2002, 346∶1706-1713.
    [12] SokalEM .DrugtreatmentofpediatricchronichepatitisB[J].PaediatrDrugs.2002, 4∶361-369.
    [13]姚光弼, 崔振宇, 姚集鲁, 等.国产拉米夫定治疗2200例慢性乙型肝炎的Ⅳ期临床试验[J].中华肝脏病杂志, 2003, 11∶103-108.
    [14] DienstagJL , CianciaraJ, KarayalcinS , etal.DurabilityofserologicresponseafterlamivudinetreatmentofchronichepatitisB[J].Hepatolo gy, 2003, 37∶748-755.
    [15] SchiffER , LaiCL , HadziyannisS , etal.Adefovirdipivoxiltherapyforlamivudine-resistanthepatitisBinpre-andpost-livertransplan-tationpatients[J].Hepatology, 2003, 38∶1419-1427.
    [16] LiawYF , LeungNW , ChangTT , etal.EffectsofextendedlamivudinetherapyinAsianpatientswithchronichepatitisB[J].Gastroenterology, 2000, 119∶172-180.
    [17] ChangTT , LaiCL , LiawYF , etal.IncrementalincreasesinHBeAgseroconversionandcontinuedALTnormalizationinAsianchronicHBV (CHB) patientstreatedwithlamivudineforfouryears[J].AntiviralTherapy, 2000, 5 (Suppl1) ∶44.
    [18] SongBC , SuhDJ, LeeHC , etal.HepatitisBeantigenseroconversionafterlamivudinetherapyisnotdurableinpatientswithchronichepatitisBinKorea[J].Hepatology, 2000, 32∶803-806.
    [19] HonkoopP , deManRA , NiestersHG , etal.AcuteexacerbationofchronichepatitisBvirusinfectionafterwithdrawaloflamivudinetherapy[J].Hepatology, 2000, 32∶635-639.
    [20] KobayashiS , IdeT , SataM , etal.DetectionofYMDDmotifmutationsinsomelamivudine-untreatedasymptomatichepatitisBviruscarriers[J].JHepatol, 2001, 34∶584-586.
    [21]KirishimaT , OkanoueT , DaimonY , etal.DetectionofYMDDmutantusinganovelsensitivemethodinchronicliverdiseasetypeBpatientsbe foreandduringlamivudinetreatment[J].JHepatol, 2002, 37∶259-265.
    [22] ZhangXX , LiuCM , GongQM , etal.Evolutionofwildtypeandmu tantsoftheYMDDmotifofhepatitisBviruspolymeraseduringlamivudinetherapy[J].JGastroenteroloHepatolo, 2003, 1353-1357.
    [23] SchalmSW , HeathcoteJ, CianciaraJ , etal.Lamivudineandalphain terferoncombinationtreatmentofpatientswithchronichepatitisBinfec tion:arandomisedtrial[J].Gut, 2000, 46∶562-568.
    [24] MariaButi, RafaelEsteban.Entecavir, FTC , L -RMAU , LdTandothers[J].JHepatol, 2003, 39∶S139-S142.
  • 加载中
计量
  • 文章访问数:  1885
  • HTML全文浏览量:  4
  • PDF下载量:  940
  • 被引次数: 0
出版历程
  • 出版日期:  2004-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回